Jaroslav Januška

1.4k total citations
62 papers, 964 citations indexed

About

Jaroslav Januška is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Jaroslav Januška has authored 62 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Jaroslav Januška's work include Cardiac Arrhythmias and Treatments (23 papers), Cardiomyopathy and Myosin Studies (22 papers) and Cardiovascular Function and Risk Factors (19 papers). Jaroslav Januška is often cited by papers focused on Cardiac Arrhythmias and Treatments (23 papers), Cardiomyopathy and Myosin Studies (22 papers) and Cardiovascular Function and Risk Factors (19 papers). Jaroslav Januška collaborates with scholars based in Czechia, Germany and Poland. Jaroslav Januška's co-authors include Martin Fiala, Josef Veselka, Jan Krejčí, Maciej Dąbrowski, Radka Adlová, Lothar Faber, Hubert Seggewiß, Max Liebregts, Peter Riis Hansen and Jurriën M. ten Berg and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Jaroslav Januška

54 papers receiving 927 citations

Peers

Jaroslav Januška
Leonardo Liberman United States
M Wieczorek Germany
Hicham El Masry United States
I Maté Spain
Charles B. Upshaw United States
Ameeta B. Martin United States
Rebecca Hughes United Kingdom
C. Richard Morris United States
Leonardo Liberman United States
Jaroslav Januška
Citations per year, relative to Jaroslav Januška Jaroslav Januška (= 1×) peers Leonardo Liberman

Countries citing papers authored by Jaroslav Januška

Since Specialization
Citations

This map shows the geographic impact of Jaroslav Januška's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaroslav Januška with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaroslav Januška more than expected).

Fields of papers citing papers by Jaroslav Januška

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaroslav Januška. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaroslav Januška. The network helps show where Jaroslav Januška may publish in the future.

Co-authorship network of co-authors of Jaroslav Januška

This figure shows the co-authorship network connecting the top 25 collaborators of Jaroslav Januška. A scholar is included among the top collaborators of Jaroslav Januška based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaroslav Januška. Jaroslav Januška is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Majewski, Michał, Andrzej Kułach, Jaroslav Januška, et al.. (2025). Impaired occluders endothelialization after transcatheter paravalvular leak closure. Kardiologia Polska. 83(5). 626–628. 2 indexed citations
3.
Januška, Jaroslav, et al.. (2025). Association of residual shunts after PFO closure with recurrent stroke risk: Single-center experience. Kardiologia Polska. 83(11). 1268–1275.
4.
Dostálová, Gabriela, et al.. (2024). Anderson–Fabry Disease Homozygosity: Rare Case of Late-Onset Variant. SHILAP Revista de lepidopterología. 14(2). 74–83. 1 indexed citations
5.
Januška, Jaroslav, et al.. (2022). Virtual reality–assisted heart team consultation for complex structural heart intervention. European Heart Journal - Case Reports. 7(1). ytac477–ytac477. 2 indexed citations
6.
Veselka, Josef, Max Liebregts, Robert Cooper, et al.. (2022). Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation. JACC: Cardiovascular Interventions. 15(19). 1910–1917. 12 indexed citations
7.
Šrámek, Martin, T Honĕk, Aleš Tomek, et al.. (2021). Screening and Risk Stratification Strategy Reduced Decompression Sickness Occurrence in Divers With Patent Foramen Ovale. JACC. Cardiovascular imaging. 15(2). 181–189. 12 indexed citations
8.
Veselka, Josef, Lothar Faber, Max Liebregts, et al.. (2021). Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy. International Journal of Cardiology. 333. 127–132. 10 indexed citations
9.
Veselka, Josef, Lothar Faber, Max Liebregts, et al.. (2019). Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis. European Heart Journal. 40(21). 1681–1687. 27 indexed citations
10.
Neuwirth, Radek, Jakub Cvek, Lukáš Knybel, et al.. (2019). Stereotactic radiosurgery for ablation of ventricular tachycardia. EP Europace. 21(7). 1088–1095. 124 indexed citations
11.
Šrámek, Martin, Luděk Šefc, Jaroslav Januška, et al.. (2019). High-grade patent foramen ovale is a risk factor of unprovoked decompression sickness in recreational divers. Journal of Cardiology. 74(6). 519–523. 18 indexed citations
12.
Tomašov, Pavol, Radka Adlová, Jaroslav Januška, et al.. (2019). Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Archives of Medical Science. 15(3). 650–655. 7 indexed citations
13.
Fiala, Martin, et al.. (2016). Functional improvement after successful catheter ablation for long-standing persistent atrial fibrillation. EP Europace. 19(11). euw282–euw282. 14 indexed citations
14.
Veselka, Josef, Morten K. Jensen, Max Liebregts, et al.. (2016). Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. European Heart Journal. 37(19). 1517–1523. 132 indexed citations
15.
Šrámek, Martin, Luděk Šefc, Jaroslav Januška, et al.. (2014). Effect of Catheter-Based Patent Foramen Ovale Closure on the Occurrence of Arterial Bubbles in Scuba Divers. JACC: Cardiovascular Interventions. 7(4). 403–408. 37 indexed citations
16.
Veselka, Josef, Jan Krejčí, Pavol Tomašov, et al.. (2014). Survival of Patients ≤ 50 Years of Age After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Canadian Journal of Cardiology. 30(6). 634–638. 17 indexed citations
18.
Januška, Jaroslav, et al.. (2007). Closure of a post-infarction ventricular septal defect using the Amplatz occluder. Cor et Vasa. 49(7-8). 254–258.
19.
Honĕk, T, Josef Veselka, Aleš Tomek, et al.. (2006). Foramen ovale patens jako příčina paradoxní embolizace u sportovních potápěčů. Cor et Vasa. 48. 286–288. 1 indexed citations
20.
Brát, Radim, et al.. (2000). Comparison Between Blood and Crystalloid Cardioplegia in Patients with Left Ventricular Dysfunction Undergoing Coronary Surgery. Acta Medica (Hradec Kralove Czech Republic). 43(3). 107–110. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026